Document is current
Any future updates will be listed below
-
Authors
Sonis, Stephen
Wardill, Hannah
Villa, Alessandro
- License Information
-
More Information
Article History
Received: 30 April 2026
Accepted: 15 May 2026
First Online: 25 May 2026
Declarations
:
: Hannah Wardill declares no conflict of interest. Stephen Sonis is an employee of Biomodels LLC and Primary endpoint solutions, LLC and is involved in assisting industry government and academics in the study and enablement of drugs, biologicals and devices to treat patients for a broader range of indications including cancer regimen related toxicity disease such as oral mucositis. Alessandro Villa is a consultant for Amgen, GSK, Merck, Mureva, Primary endpoint solutions, and Novartis. He received research grants from NIH, PCCA, MeiraGtx, and Merck.
: Not applicable.
